BACKGROUND: The global incidence of breast cancer (BC) is rising, especially in low- and middle-income countries. The purpose of this review is to summarize existing publications on BC care in Africa. PATIENTS AND METHODS: A systematic search in MEDLINE and smaller databases was carried out to identify African studies on BC treatment, and an additional PubMed search was performed for relevant topics on BC care. RESULTS: A total of 219 publications, mainly from North and West Africa, were found by systematic search. We also selected articles on BC epidemiology, risk factors, clinical presentation, and cancer control in Africa. CONCLUSIONS: Publications on BC treatment are mostly from hospital case series. Evidence on treatment from prospective randomized trials that address the specific characteristics of African patients is lacking. The epidemiologic data shows rising incidences in Africa. The prevalence of risk factors is changing by age group, geographic region, and over time. The clinical picture of BC differs from that of Western countries due to the high proportion of young patients (on account of the African population with a high proportion of young people) and late presentation. Global collaborative efforts are needed to address the rising need for improved BC care in Africa.
BACKGROUND: The global incidence of breast cancer (BC) is rising, especially in low- and middle-income countries. The purpose of this review is to summarize existing publications on BC care in Africa. PATIENTS AND METHODS: A systematic search in MEDLINE and smaller databases was carried out to identify African studies on BC treatment, and an additional PubMed search was performed for relevant topics on BC care. RESULTS: A total of 219 publications, mainly from North and West Africa, were found by systematic search. We also selected articles on BC epidemiology, risk factors, clinical presentation, and cancer control in Africa. CONCLUSIONS: Publications on BC treatment are mostly from hospital case series. Evidence on treatment from prospective randomized trials that address the specific characteristics of African patients is lacking. The epidemiologic data shows rising incidences in Africa. The prevalence of risk factors is changing by age group, geographic region, and over time. The clinical picture of BC differs from that of Western countries due to the high proportion of young patients (on account of the African population with a high proportion of young people) and late presentation. Global collaborative efforts are needed to address the rising need for improved BC care in Africa.
Entities:
Keywords:
Africa; Breast neoplasms; Outcome; Review; Therapy
Authors: H Kohail; S Shehata; O Mansour; Y Gouda; R Gaafar; T A Hamid; S El Nowieam; A Al Khodary; H El Zawahry; A A Wareth; I A Halim; F A Taleb; E Hamada; M Barsoum; M Abdullah; M Meshref Journal: Hematol Oncol Stem Cell Ther Date: 2012
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Cesaltina Lorenzoni; Alba Vilajeliu; Carla Carrilho; Mamudo R Ismail; Paola Castillo; Orvalho Augusto; Alberto L García-Basteiro; Mohsin Sidat; Silvia de Sanjosé; Clara Menéndez; Jaume Ordi Journal: PLoS One Date: 2015-06-25 Impact factor: 3.240
Authors: Babatunde Adedokun; Yonglan Zheng; Paul Ndom; Antony Gakwaya; Timothy Makumbi; Alicia Y Zhou; Toshio F Yoshimatsu; Alex Rodriguez; Ravi K Madduri; Ian T Foster; Aminah Sallam; Olufunmilayo I Olopade; Dezheng Huo Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-12-23 Impact factor: 4.254
Authors: Abdou Azaque Zouré; Aboubacar Hierrhum Bambara; Alexis Yobi Sawadogo; Abdoul Karim Ouattara; Marie Ouédraogo; Si Simon Traoré; Youssef Bakri; Jacques Simporé Journal: Asian Pac J Cancer Prev Date: 2016-12-01
Authors: Leonie Ströbele; Eva Johanna Kantelhardt; Timongo Francoise Danielle Traoré Millogo; Maurice Sarigda; Jürgen Wacker; Kirstin Grosse Frie Journal: BMC Public Health Date: 2018-04-04 Impact factor: 3.295